| ADL | Activities of Daily Living |
| ASICs | Acid-Sensing Ion Channels |
| CPG | Clinical Practice Guidelines |
| ECM | Extracellular Matrix |
| ERK | Extracellular Signal-Regulated Kinase |
| GAG | Glycosaminoglycan |
| HA | Hyaluronic Acid |
| HAS1 | Hyaluronan Synthase 1 |
| HMW | High Molecular Weight |
| HOA | Hip Osteoarthritis |
| IAHA | Intra-Articular Hyaluronic Acid |
| IL-1β | Interleukin One Beta |
| KOA | Knee Osteoarthritis |
| LMW | Low Molecular Weight |
| MAPK | Mitogen-Activated Protein Kinase |
| MMPs | Matrix Metalloproteinases |
| NADP | Nicotinamide Adenine Dinucleotide Phosphate |
| NF-κB | Nuclear Factor Kappa-Light-Chain-Enhancer |
| OA | Osteoarthritis |
| OPG | Osteoprotegerin |
| PCM | Pericellular Matrix |
| PGE2 | Prostaglandin E2 |
| PI3K | Phosphoinositide Three Kinase |
| RCT | Randomized Clinical Trial |
| RHAMM | Receptor for Hyaluronan-Mediated Motility |
| RANKL | Receptor Activator of Nuclear Factor Kappa-B Ligand |
| ROS | Reactive Oxygen Species |
| TGF-β | Transforming Growth Factor Beta |
| TKA | Total Knee Arthroplasty |
| TKA | Total Knee Replacement |
| TLR | Toll-Like Receptor |
| TNF-α | Tumor Necrosis Factor Alpha |
| TRPV1 | Transient Receptor Vanilloid Potential 1 |
| UDP | Uridine Diphosphate |
| UDP-GlcUA | UDP-α-D-Glucuronate |
| UHMW | Ultra High Molecular Weight |
| VS | Viscosupplementation |
| WHO | World Health Organization |